BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 9823006)

  • 21. Two novel 14-Epi-analogues of 1,25-dihydroxyvitamin D3 inhibit the growth of human breast cancer cells in vitro and in vivo.
    Verlinden L; Verstuyf A; Van Camp M; Marcelis S; Sabbe K; Zhao XY; De Clercq P; Vandewalle M; Bouillon R
    Cancer Res; 2000 May; 60(10):2673-9. PubMed ID: 10825140
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Interaction of two novel 14-epivitamin D3 analogs with vitamin D3 receptor-retinoid X receptor heterodimers on vitamin D3 responsive elements.
    Verlinden L; Verstuyf A; Quack M; Van Camp M; Van Etten E; De Clercq P; Vandewalle M; Carlberg C; Bouillon R
    J Bone Miner Res; 2001 Apr; 16(4):625-38. PubMed ID: 11315990
    [TBL] [Abstract][Full Text] [Related]  

  • 23. 1α,25(OH)2D3 Analog, MART-10, Inhibits Neuroendocrine Tumor Cell Growth Through Induction of G0/G1 Cell-cycle Arrest and Apoptosis.
    Chiang KC; Yeh CN; Pang JH; Hsu JT; Yeh TS; Chen LW; Kuo SF; Hsieh PJ; Pan YC; Takano M; Chen TC; Feng TH; Kittaka A; Juang HH
    Anticancer Res; 2016 Jul; 36(7):3307-13. PubMed ID: 27354587
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Altered expression of estrogen-regulated genes in a tamoxifen-resistant and ICI 164,384 and ICI 182,780 sensitive human breast cancer cell line, MCF-7/TAMR-1.
    Lykkesfeldt AE; Madsen MW; Briand P
    Cancer Res; 1994 Mar; 54(6):1587-95. PubMed ID: 8137264
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Vitamin D growth inhibition of breast cancer cells: gene expression patterns assessed by cDNA microarray.
    Swami S; Raghavachari N; Muller UR; Bao YP; Feldman D
    Breast Cancer Res Treat; 2003 Jul; 80(1):49-62. PubMed ID: 12889598
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Apoptotic regression of MCF-7 xenografts in nude mice treated with the vitamin D3 analog, EB1089.
    VanWeelden K; Flanagan L; Binderup L; Tenniswood M; Welsh J
    Endocrinology; 1998 Apr; 139(4):2102-10. PubMed ID: 9528999
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Resistance of human breast-cancer cells to the pure steroidal anti-estrogen ICI 182,780 is not associated with a general loss of estrogen-receptor expression or lack of estrogen responsiveness.
    Larsen SS; Madsen MW; Jensen BL; Lykkesfeldt AE
    Int J Cancer; 1997 Sep; 72(6):1129-36. PubMed ID: 9378550
    [TBL] [Abstract][Full Text] [Related]  

  • 28. CCAAT/enhancer-binding protein delta: a molecular target of 1,25-dihydroxyvitamin D3 in androgen-responsive prostate cancer LNCaP cells.
    Ikezoe T; Gery S; Yin D; O'Kelly J; Binderup L; Lemp N; Taguchi H; Koeffler HP
    Cancer Res; 2005 Jun; 65(11):4762-8. PubMed ID: 15930295
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Efficacy and mechanism of action of 1alpha-hydroxy-24-ethyl-cholecalciferol (1alpha[OH]D5) in breast cancer prevention and therapy.
    Hussain EA; Mehta RR; Ray R; Das Gupta TK; Mehta RG
    Recent Results Cancer Res; 2003; 164():393-411. PubMed ID: 12899538
    [TBL] [Abstract][Full Text] [Related]  

  • 30. MART-10, a less calcemic vitamin D analog, is more potent than 1α,25-dihydroxyvitamin D3 in inhibiting the metastatic potential of MCF-7 breast cancer cells in vitro.
    Chiang KC; Chen SC; Yeh CN; Pang JH; Shen SC; Hsu JT; Liu YY; Chen LW; Kuo SF; Takano M; Kittaka A; Sun CC; Juang HH; Chen TC
    J Steroid Biochem Mol Biol; 2014 Jan; 139():54-60. PubMed ID: 24125734
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Involvement of G1/S cyclins in estrogen-independent proliferation of estrogen receptor-positive breast cancer cells.
    Bindels EM; Lallemand F; Balkenende A; Verwoerd D; Michalides R
    Oncogene; 2002 Nov; 21(53):8158-65. PubMed ID: 12444551
    [TBL] [Abstract][Full Text] [Related]  

  • 32. 19-nor-26,27-bishomo-vitamin D3 analogs: a unique class of potent inhibitors of proliferation of prostate, breast, and hematopoietic cancer cells.
    Kubota T; Koshizuka K; Koike M; Uskokovic M; Miyoshi I; Koeffler HP
    Cancer Res; 1998 Aug; 58(15):3370-5. PubMed ID: 9699668
    [TBL] [Abstract][Full Text] [Related]  

  • 33. MCF7/LCC9: an antiestrogen-resistant MCF-7 variant in which acquired resistance to the steroidal antiestrogen ICI 182,780 confers an early cross-resistance to the nonsteroidal antiestrogen tamoxifen.
    Brünner N; Boysen B; Jirus S; Skaar TC; Holst-Hansen C; Lippman J; Frandsen T; Spang-Thomsen M; Fuqua SA; Clarke R
    Cancer Res; 1997 Aug; 57(16):3486-93. PubMed ID: 9270017
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Vitamin-D3 derivatives and breast-tumor cell growth: effect on intracellular calcium and apoptosis.
    Vandewalle B; Hornez L; Wattez N; Revillion F; Lefebvre J
    Int J Cancer; 1995 Jun; 61(6):806-11. PubMed ID: 7790115
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Amphiregulin is a vitamin D3 target gene in squamous cell and breast carcinoma.
    Akutsu N; Bastien Y; Lin R; Mader S; White JH
    Biochem Biophys Res Commun; 2001 Mar; 281(4):1051-6. PubMed ID: 11237771
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of 1,25-dihydroxyvitamin D3 on cell-cycle kinetics of T 47D human breast cancer cells.
    Eisman JA; Sutherland RL; McMenemy ML; Fragonas JC; Musgrove EA; Pang GY
    J Cell Physiol; 1989 Mar; 138(3):611-6. PubMed ID: 2925799
    [TBL] [Abstract][Full Text] [Related]  

  • 37. 1,25-Dihydroxyvitamin D3 inhibits growth of the breast cancer cell line MCF-7 and downregulates cytochrome P4501B1 through the COX-2/PGE2 pathway.
    Yuan L; Jiang R; Yang Y; Ding S; Deng H
    Oncol Rep; 2012 Dec; 28(6):2131-7. PubMed ID: 22971613
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Differential regulation of specific genes in MCF-7 and the ICI 182780-resistant cell line MCF-7/182R-6.
    Jensen BL; Skouv J; Lundholt BK; Lykkesfeldt AE
    Br J Cancer; 1999 Feb; 79(3-4):386-92. PubMed ID: 10027303
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mifepristone induces growth arrest, caspase activation, and apoptosis of estrogen receptor-expressing, antiestrogen-resistant breast cancer cells.
    Gaddy VT; Barrett JT; Delk JN; Kallab AM; Porter AG; Schoenlein PV
    Clin Cancer Res; 2004 Aug; 10(15):5215-25. PubMed ID: 15297425
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inhibition of serum-stimulated mitogen activated protein kinase by 1alpha,25(OH)2-vitamin D3 in MCF-7 breast cancer cells.
    Capiati DA; Rossi AM; Picotto G; Benassati S; Boland RL
    J Cell Biochem; 2004 Oct; 93(2):384-97. PubMed ID: 15368364
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.